Gunawardhana L P, Gibson P G, Simpson J L, Powell H, Baines K J
Priority Research Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, The University of Newcastle, Newcastle, NSW, Australia; Department of Respiratory & Sleep Medicine, HMRI, John Hunter Hospital, New Lambton, NSW, Australia.
Clin Exp Allergy. 2014 Jan;44(1):47-57. doi: 10.1111/cea.12168.
Histone acetyltransferases (HATs) and histone deacetylases (HDACs) regulate gene expression, yet differences in the activity of these enzymes in the inflammatory phenotypes of asthma are unknown. We hypothesized that neutrophilic asthma (NA) would be associated with increased HAT and decreased HDAC activity.
To investigate total HAT/HDAC activity and gene expression in isolated blood monocytes and sputum macrophages from healthy and patients with asthma.
Peripheral blood and induced sputum were collected from adults with asthma (n = 52) and healthy controls (n = 9). Sputum inflammatory cell counts were performed and asthma inflammatory phenotypes were classified according to sputum eosinophil and neutrophil cut-off's of > 3% and > 61% respectively. Peripheral blood monocytes were isolated (n = 61) and sputum macrophages were isolated from a subgroup of patients with asthma (n = 14), using immunomagnetic cell separation. RNA and nuclear proteins were extracted and quantified. Enzyme activity was assessed using fluorescent assays and gene expression of EP300, KAT2B, CREBBP, and HDACs 1, 2 and 3 were measured by qPCR.
There was a significant inverse association between blood monocyte HAT and HDAC activity (r = -0.58, P < 0.001). NA was associated with increased blood monocyte HAT enzyme activity (P = 0.02), decreased HDAC activity (P = 0.03), and increased HAT: HDAC ratio (P < 0.01) compared with eosinophilic asthma. There were no differences in gene expression of EP300, KAT2B, CREBBP, or HDACs 1, 2 and 3 in blood monocytes from subjects with asthma or inflammatory phenotypes of asthma. There was no effect of inhaled corticosteroid use, poor asthma control, or asthma severity on HAT/HDAC activities. Sputum macrophages had increased expression of KAT2B in eosinophilic compared with paucigranulocytic asthma.
Neutrophilic airway inflammation is associated with increased HAT and reduced HDAC activity in blood monocytes, demonstrating further systemic manifestations relating to the altered inflammatory gene transcription profile of neutrophilic asthma.
组蛋白乙酰转移酶(HATs)和组蛋白去乙酰化酶(HDACs)调节基因表达,但这些酶在哮喘炎症表型中的活性差异尚不清楚。我们推测嗜中性粒细胞性哮喘(NA)与HAT活性增加和HDAC活性降低有关。
研究健康人和哮喘患者分离的血液单核细胞和痰液巨噬细胞中的总HAT/HDAC活性及基因表达。
收集成年哮喘患者(n = 52)和健康对照者(n = 9)的外周血和诱导痰液。进行痰液炎症细胞计数,并根据痰液嗜酸性粒细胞和中性粒细胞分别> 3%和> 61%的临界值对哮喘炎症表型进行分类。使用免疫磁珠细胞分离法从哮喘患者亚组(n = 14)中分离外周血单核细胞(n = 61)和痰液巨噬细胞。提取并定量RNA和核蛋白。使用荧光测定法评估酶活性,并通过qPCR测量EP300、KAT2B、CREBBP以及HDACs 1、2和3的基因表达。
血液单核细胞HAT和HDAC活性之间存在显著负相关(r = -0.58,P < 0.001)。与嗜酸性粒细胞性哮喘相比,NA与血液单核细胞HAT酶活性增加(P = 0.02)、HDAC活性降低(P = 0.03)以及HAT:HDAC比值增加(P < 0.01)相关。哮喘患者或哮喘炎症表型患者的血液单核细胞中EP300、KAT2B、CREBBP或HDACs 1、2和3的基因表达无差异。吸入糖皮质激素的使用、哮喘控制不佳或哮喘严重程度对HAT/HDAC活性无影响。与少粒细胞性哮喘相比,嗜酸性粒细胞性哮喘患者痰液巨噬细胞中KAT2B的表达增加。
嗜中性粒细胞气道炎症与血液单核细胞中HAT活性增加和HDAC活性降低有关,这表明嗜中性粒细胞性哮喘炎症基因转录谱改变存在进一步的全身表现。